- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06300151
The Effect of Ultrasound Real-time Guidance Technique on the Effectiveness and Safety of Labor Analgesia
August 18, 2025 updated by: Zongxun Lin
Ultrasound real-time guidance technology has great advantages over traditional blind exploration technology in terms of accuracy, success rate, and reduction of puncture damage in intervertebral space positioning through operational visualization, greatly improving the effectiveness and safety of spinal block.
At present, Doppler ultrasound is rarely used for spinal block, especially for real-time ultrasound guidance technology, which has not been widely applied in clinical practice due to its high equipment requirements, lack of mature puncture plans, complex operation, and high learning curve.
If a comprehensive diagnosis and treatment plan can be developed, it will greatly improve the delivery experience of mothers.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Traditional blind exploration of spinal canal puncture has many limitations, often forcing changes in anesthesia methods due to multiple puncture failures.
However, the application of real-time ultrasound guidance technology in spinal canal puncture can completely solve this clinical difficulty.
The ultrasound-guided real-time paramedian approach epidural puncture for labor analgesia is a new type of labor analgesia technology, and its specific operating standards and diagnostic and treatment routines have not yet been established, including the selection of puncture path, puncture needle model, distance between puncture hole and epidural injection point, drug type, dosage, solubility, volume and other parameters, all of which have great research space.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zongxun Lin, Master
- Phone Number: +8613763820916
- Email: 13763820916@189.cn
Study Locations
-
-
Fujian
-
Fuzhou, Fujian, China, 350001
- Recruiting
- Fujian Provincial Hospital
-
Contact:
- Zongxun Lin, Master
- Phone Number: +8613763820916
- Email: 13763820916@189.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) Class I or II;
- Single healthy pregnancy;
- Head showing first;
- 37 to 41 weeks;
- The labor process is active, and the cervix dilates<5cm;
- Require epidural labor analgesia;
- Volunteer to participate in this study and sign an informed consent form.
Exclusion Criteria:
- Presence of pregnancy diseases, such as pregnancy hypertension, pre eclampsia, pregnancy diabetes;
- Contraindications to intraspinal analgesia: 1) Central nervous system diseases. 2) Infection or septicemia at the puncture site. 3) Coagulation dysfunction;
- Known cases of fetal malformation or increased risk of cesarean section, such as a history of uterine rupture;
- Persons with a history of mental illness, hysteria, epilepsy, etc. who cannot cooperate.
- Patients with long-term use of opioids, steroids, and chronic pain.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ultrasound Real-time Guidance combined with Dural Puncture Epidural Group
Ultrasound real-time guidance combined with dural puncture epidural Can improve the clinical effect of labor analgesia.
|
Ultrasound real-time guidance technology has great advantages over traditional blind exploration technology in terms of accuracy, success rate, and reduction of puncture damage in intervertebral space positioning through operational visualization, greatly improving the effectiveness and safety of spinal block.
|
|
Active Comparator: Dural Puncture Epidural Group
Dural Puncture Epidural is a clinical improvement of Combined Spinal-Epidural and is widely used in Maternal.
The implementation step is to complete the epidural puncture, temporarily do not place a tube, puncture the dura mater with a subarachnoid anesthesia needle, but do not directly inject drugs into the subarachnoid space, and then leave an epidural catheter for administration according to epidural block.
|
Dural Puncture Epidural is a clinical improvement of Combined Spinal-Epidural and is widely used in Maternal.
The implementation step is to complete the epidural puncture, temporarily do not place a tube, puncture the dura mater with a subarachnoid anesthesia needle, but do not directly inject drugs into the subarachnoid space, and then leave an epidural catheter for administration according to epidural block.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analgesic effect(onset time)
Time Frame: 7 weeks
|
Analgesic effect of pregnant women(onset time)
|
7 weeks
|
|
Analgesic effect(block level)
Time Frame: 7 weeks
|
block level of pregnant women by Alcohol swab(temperature sensation:Pubic symphysis=T12,umbilical region=T10,hypochondrium=T8,xiphoid process=T6,Nipple connection=T4,subclavian=T2)
|
7 weeks
|
|
Analgesic effect(block effect)
Time Frame: 7 weeks
|
block effect of pregnant women by Alcohol swab(temperature sensation:Unblocked, unilateral block, bilateral block)
|
7 weeks
|
|
Analgesic effect(Visual Analogue Scale)
Time Frame: 7 weeks
|
Analgesic effect of pregnant women by Visual Analogue Scale(scale title=Visual Analogue Scale,Total score=0-10,0=no pain,10=worst possible pain)
|
7 weeks
|
|
Uterine contraction indicators(Frequency)
Time Frame: 7 weeks
|
Assess uterine contractions(Frequency)
|
7 weeks
|
|
Uterine contraction indicators(duration)
Time Frame: 7 weeks
|
Assess uterine contractions(duration)
|
7 weeks
|
|
Uterine contraction indicators(Number of pregnant women with Tachysystole)
Time Frame: 7 weeks
|
Tachysystole=More than 5 Uterine contraction in 10 minutes
|
7 weeks
|
|
Uterine contraction indicators(Number of pregnant women with hypertonus)
Time Frame: 7 weeks
|
hypertonus=Each Uterine contraction lasts for more than 2 minutes
|
7 weeks
|
|
Fetal heart indicators(Fetal heart rate)
Time Frame: 7 weeks
|
Assess fetal heart(Fetal heart rate)
|
7 weeks
|
|
Fetal heart indicators(NICHD classification)
Time Frame: 7 weeks
|
Assess fetal heart(NICHD classification)
|
7 weeks
|
|
Fetal heart indicators(Fetal Heart Rate decelerations)
Time Frame: 7 weeks
|
Assess fetal heart(Fetal Heart Rate decelerations)
|
7 weeks
|
|
Fetal heart indicators(Fetal Heart Rate Variability)
Time Frame: 7 weeks
|
Assess fetal heart(Fetal Heart Rate Variability)
|
7 weeks
|
|
Apgar score
Time Frame: 7 weeks
|
Apgar score(scale title=Apgar score,Total score=0-10,0-3=severe asphyxia,4-7=mild asphyxia,8-10=normal)
|
7 weeks
|
|
modified bromage score
Time Frame: 7 weeks
|
modified bromage score(scale title=modified bromage score,Total score=0-3,0=no Motor nerve block; 1=unable to lift straight legs, but able to bend knees and move feet; 2=unable to lift straight legs or bend knees, but able to move feet; 3=unable to bend ankles, feet, or knees (completely blocked))
|
7 weeks
|
|
Analgesic effect(number of Patient controlled analgesia)
Time Frame: 7 weeks
|
number of Patient controlled analgesia(Press the PCA button when the patient feels pain)
|
7 weeks
|
|
Analgesic effect(time of Patient controlled analgesia)
Time Frame: 7 weeks
|
time of Patient controlled analgesia(Press the PCA button when the patient feels pain)
|
7 weeks
|
|
Sacral sensory block of pregnant women
Time Frame: 7 weeks
|
Sacral sensory block of pregnant women by Alcohol swab(temperature sensation:Unblocked, unilateral block, bilateral block)
|
7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operation evaluation(Time)
Time Frame: 7 weeks
|
Assessment of puncture condition(Time)
|
7 weeks
|
|
Operation evaluation(number of times)
Time Frame: 7 weeks
|
Assessment of puncture condition(number of times)
|
7 weeks
|
|
Operation evaluation(side effects and Complications)
Time Frame: 7 weeks
|
Assessment of puncture condition(side effects and Complications)
|
7 weeks
|
|
Delivery mode
Time Frame: 7 weeks
|
natural labor/cesarean section/instrument
|
7 weeks
|
|
Concentration of Interleukin 6
Time Frame: 7 weeks
|
Pregnant women's venous blood Interleukin 6
|
7 weeks
|
|
Concentration of hypersensitive C-reactive protein
Time Frame: 7 weeks
|
Pregnant women's venous blood hypersensitive C-reactive protein
|
7 weeks
|
|
Concentration of cortisol
Time Frame: 7 weeks
|
Pregnant women's venous blood cortisol
|
7 weeks
|
|
Maternal rehabilitation indicators(Postpartum hospital stay)
Time Frame: 7 weeks
|
Postpartum hospitalization days
|
7 weeks
|
|
Maternal rehabilitation indicators(Edinburgh Postnatal Depression Scale)
Time Frame: 7 weeks
|
Edinburgh Postnatal Depression Scale(scale title=Edinburgh Postnatal Depression Scale,Total score=0-30,≥13=Postpartum depression)
|
7 weeks
|
|
Maternal rehabilitation indicators(Postoperative Recovery Quality Scale(QOR-40))
Time Frame: 7 weeks
|
Postoperative Recovery Quality Scale(QOR-40)(scale title=Postoperative Recovery Quality Scale(QOR-40),Total score=0-200,The higher the score the better the recovery)
|
7 weeks
|
|
Number of pregnant women with adjust the treatment plan and adjustment method
Time Frame: 7 weeks
|
adjustment method include Adjust the Epidural catheter or Adjusting drug dosage
|
7 weeks
|
|
Drug consumption
Time Frame: 7 weeks
|
Drug consumption
|
7 weeks
|
|
Effect of stages of labor(time)
Time Frame: 7 weeks
|
Effect of stages of labor(time)
|
7 weeks
|
|
body temperature changes
Time Frame: 7 weeks
|
body temperature changes
|
7 weeks
|
|
Number of pregnant women with Infection during labor
Time Frame: 7 weeks
|
whether Infection during labor of pregnant women
|
7 weeks
|
|
Side effects and complications of labor analgesia
Time Frame: 7 weeks
|
Side effects and complications of labor analgesia
|
7 weeks
|
|
Self-Rating Anxiety Scale
Time Frame: 7 weeks
|
Self-Rating Anxiety Scale(scale title=Self-Rating Anxiety Scale,Total score=0-80,≥50=Anxiety)
|
7 weeks
|
|
Delivery fear score(numerical rating scale)
Time Frame: 7 weeks
|
Delivery fear score by numerical rating scale(scale title=numerical rating scale,Total score=0-10,≥6=Delivery fear)
|
7 weeks
|
|
Delivery satisfaction survey
Time Frame: 7 weeks
|
Delivery satisfaction survey(0=very satisfied, 1=satisfied, 2=common, 3=dissatisfied)
|
7 weeks
|
|
The reasons and number of pregnant women with conversion of natural labor to Caesarean section
Time Frame: 7 weeks
|
Reasons and number for conversion of natural labor to Caesarean section (pregnant woman, fetus, anesthesia, others)
|
7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zongxun Lin, Master, Fujian Provincial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2024
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
March 1, 2024
First Submitted That Met QC Criteria
March 7, 2024
First Posted (Actual)
March 8, 2024
Study Record Updates
Last Update Posted (Actual)
August 22, 2025
Last Update Submitted That Met QC Criteria
August 18, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ultrasound Real-time Guidance
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Analgesia
-
Yale UniversityNot yet recruitingLabor AnalgesiaUnited States
-
Nanjing Maternity and Child Health Care HospitalUnknown
-
University of California, San FranciscoRecruitingPregnancy | Labor Analgesia | Labor and DeliveryUnited States
-
Hospital Universitario La PazCompletedLabor Epidural AnalgesiaSpain
-
University of CagliariUnknownEpidural Analgesia | Labor | Nulliparous
-
Ohio State UniversityWithdrawnAdministration Methods of Labor AnalgesiaUnited States
-
Sohag UniversityCompletedEpidural Analgesia | Cesarean Section | Painless LaborEgypt
-
Tanta UniversityCompletedEpidural Analgesia | Dexmedetomidine | Fentanyl | Painless Labor | LevobupivacaineEgypt
-
Da Nang Family General HospitalRecruitingLabor Pain | Labor, Obstetric | Analgesia, Epidural | Analgesia, ObstetricalVietnam
-
The Chaim Sheba Medical CenterNot yet recruitingFetal Heart Rate Abnormalities | Labor Epidural Analgesia | Maternal Hypotension
Clinical Trials on Ultrasound Real-time Guidance combined with Dural Puncture Epidural Labor Analgesia
-
Zongxun LinCompleted
-
University of ChileWithdrawnAnalgesia | Rib Fractures | Thoracic Tumors | Abdomen TumorsChile
-
Brugmann University HospitalNot yet recruitingAnalgesia | Obstetric PainBelgium